Literature DB >> 11241434

Teratogen update: reproductive risks of leflunomide (Arava); a pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child.

R L Brent1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11241434     DOI： 10.1002/1096-9926(200102)63:2<106::AID-TERA1017>3.0.CO;2-R

Source DB:  PubMed          Journal:  Teratology        ISSN： 0040-3709


× No keyword cloud information.
  21 in total

1.  Catch me if you can: a national survey of rheumatologists and obstetricians on the use of DMARDs during pregnancy.

Authors:  Sonia Panchal; Manjiri Khare; Arumugam Moorthy; Ash Samanta
Journal:  Rheumatol Int       Date:  2012-03-27       Impact factor: 2.631

Review 2.  [Drug therapy during pregnancy and breast feeding. Updated summary].

Authors:  K Krüger; E Gromnica-Ihle
Journal:  Z Rheumatol       Date:  2009-03       Impact factor: 1.372

Review 3.  Safety, tolerability, and efficacy of oral therapies for relapsing-remitting multiple sclerosis.

Authors:  Jiwon Oh; Paul W O'Connor
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

Review 4.  Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.

Authors:  Ashima Makol; Kerry Wright; Shreyasee Amin
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

Review 5.  Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects.

Authors:  Jiwon Oh; Paul W O'Connor
Journal:  Ther Adv Neurol Disord       Date:  2014-09       Impact factor: 6.570

Review 6.  Use of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: what the rheumatologist needs to know.

Authors:  Megan L Krause; Shreyasee Amin; Ashima Makol
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-10       Impact factor: 5.346

7.  Metabolism studies of a small-molecule tumor necrosis factor-alpha (TNF-α) inhibitor, UTL-5b (GBL-5b).

Authors:  Jiajiu Shaw; Brian Shay; Jack Jiang; Frederick Valeriote; Ben Chen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-11-05       Impact factor: 2.441

Review 8.  The management of rheumatic diseases in pregnancy.

Authors:  K Mitchell; M Kaul; Megan E B Clowse
Journal:  Scand J Rheumatol       Date:  2010-03       Impact factor: 3.641

9.  Birth outcomes in women who have taken leflunomide during pregnancy.

Authors:  Christina D Chambers; Diana L Johnson; Luther K Robinson; Stephen R Braddock; Ronghui Xu; Janina Lopez-Jimenez; Nicole Mirrasoul; Elizabeth Salas; Yunjun J Luo; Shelia Jin; Kenneth Lyons Jones
Journal:  Arthritis Rheum       Date:  2010-05

Review 10.  Management of RA medications in pregnant patients.

Authors:  Monika Østensen; Frauke Förger
Journal:  Nat Rev Rheumatol       Date:  2009-06-09       Impact factor: 20.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.